Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 15;41(1):17.
doi: 10.1186/s41232-021-00167-6.

Updates on genetics in systemic sclerosis

Yuko Ota  1 , Masataka Kuwana  2
Affiliations
Review

Updates on genetics in systemic sclerosis

Yuko Ota et al. Inflamm Regen. .

Abstract

Systemic sclerosis (SSc) is a complex disease, in which an interaction of genetic and environmental factors plays an important role in its development and pathogenesis. A number of genetic studies, including candidate gene analysis and genome-wide association study, have found that the associated genetic variants are mainly localized in noncoding regions in the expression quantitative trait locus and influence corresponding gene expression. The gene variants identified as a risk for SSc susceptibility include those associated with innate immunity, adaptive immune response, and cell death, while there are only few SSc-associated genes involved in the fibrotic process or vascular homeostasis. Human leukocyte antigen class II genes are associated with SSc-related autoantibodies rather than SSc itself. Since the pathways between the associated genotype and phenotype are still poorly understood, further investigations using multi-omics technologies are necessary to characterize the complex molecular architecture of SSc, identify biomarkers useful to predict future outcomes and treatment responses, and discover effective drug targets.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
A DRB1 or DRB5 alleles associated with the presence of anti-topo I antibody in various ethnicities and their amino acid sequence at positions 67–71 in the third hypervariable region (HVR). B Proliferative responses of a representative topo I-reactive CD4+ T cell clone derived from an anti-topo I-positive patient with SSc in the presence of antigenic peptide-pulsed L cell transfectants expressing a series of human HLA-DR molecules harboring the DRB1 or DRB5 alleles associated with the presence of anti-topo I antibody. The peptide-induced T cell proliferation was measured by 3H-thymidine incorporation
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Varga J, Trojanowska M, Kuwana M. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Relat Disord. 2017;2(3):137–152. doi: 10.5301/jsrd.5000249. - DOI
    1. Kuwana M. Circulating anti-nuclear antibodies in systemic sclerosis: utility in diagnosis and disease subsetting. J Nippon Med Sch. 2017;84(2):56–63. doi: 10.1272/jnms.84.56. - DOI - PubMed
    1. Ota Y, Kuwana M. Endothelial cells and endothelial progenitor cells in the pathogenesis of systemic sclerosis. Eur J Rheumatol. 2020;7(Suppl 3):139–146. doi: 10.5152/eurjrheum.2019.19158. - DOI - PMC - PubMed
    1. Makol A, Reilly MJ, Rosenman KD. Prevalence of connective tissue disease in silicosis (1985-2006)-a report from the state of Michigan surveillance system for silicosis. Am J Ind Med. 2011;54(4):255–262. doi: 10.1002/ajim.20917. - DOI - PubMed
    1. Kettaneh A, Al Moufti O, Tiev KP, Chayet C, Tolédano C, Fabre B, et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies. J Rheumatol. 2007;34(1):97–103. - PubMed

LinkOut - more resources